Olema Pharmaceuticals, Inc. (OLMA)
NASDAQ: OLMA · Real-Time Price · USD
14.11
-0.48 (-3.29%)
Apr 29, 2026, 1:10 PM EDT - Market open
Olema Pharmaceuticals Employees
Olema Pharmaceuticals had 131 employees as of December 31, 2025. The number of employees increased by 35 or 36.46% compared to the previous year.
Employees
131
Change (1Y)
35
Growth (1Y)
36.46%
Revenue / Employee
n/a
Profits / Employee
-$1,240,084
Market Cap
1.23B
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) | Full-Time | Part-Time |
|---|---|---|---|---|---|
| Dec 31, 2025 | 131 | 35 | 36.46% | 131 | 0 |
| Dec 31, 2024 | 96 | 22 | 29.73% | 96 | 0 |
| Dec 31, 2023 | 74 | -12 | -13.95% | 74 | 0 |
| Dec 31, 2022 | 86 | 12 | 16.22% | 83 | 3 |
| Dec 31, 2021 | 74 | 37 | 100.00% | 73 | 1 |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Iovance Biotherapeutics | 975 |
| Novavax | 749 |
| AbCellera Biologics | 562 |
| Wave Life Sciences | 317 |
| Viridian Therapeutics | 252 |
| Maze Therapeutics | 141 |
| MapLight Therapeutics | 133 |
| ArriVent BioPharma | 77 |
OLMA News
- 7 days ago - Olema Oncology to Present Initial Clinical Data for OP-3136 at the 2026 ASCO Annual Meeting - GlobeNewsWire
- 26 days ago - Olema Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewsWire
- 6 weeks ago - Olema Oncology Reports Fourth Quarter and Full Year 2025 Financial and Operating Results - GlobeNewsWire
- 7 weeks ago - Olema Pharmaceuticals, Inc. Investigated on Behalf of Investors - Contact the DJS Law Group to Discuss Your Rights – OLMA - Business Wire
- 7 weeks ago - Why Is Olema Pharmaceuticals Stock Dropping On Monday? - Benzinga
- 2 months ago - Olema Pharmaceuticals Transcript: TD Cowen 46th Annual Health Care Conference - Transcripts
- 2 months ago - Olema Pharmaceuticals Transcript: Oppenheimer 36th Annual Healthcare Life Sciences Conference - Transcripts
- 2 months ago - Olema Pharmaceuticals Transcript: Citi’s 2026 Virtual Oncology Leadership Summit - Transcripts